Connection

CHARLES CHUANHAI GUO to Immunotherapy

This is a "connection" page, showing publications CHARLES CHUANHAI GUO has written about Immunotherapy.
Connection Strength

0.157
  1. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021 07 01; 28(4):196-208.
    View in: PubMed
    Score: 0.073
  2. Bladder cancer. Lancet. 2016 12 03; 388(10061):2796-2810.
    View in: PubMed
    Score: 0.051
  3. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021 09 23; 12(1):5606.
    View in: PubMed
    Score: 0.018
  4. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign. Eur Urol Oncol. 2019 05; 2(3):286-293.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.